latozinemab
Showing 1 - 1 of 1
Neurodegenerative Diseases Trial in Philadelphia, London (Latozinemab)
Recruiting
- Neurodegenerative Diseases
- Latozinemab
-
Philadelphia, Pennsylvania
- +1 more
Oct 30, 2023